BOC Sciences, a provider of CDMO services for the development of microbial drugs, recently announced that it has improved its fermentation CDMO platform to provide a comprehensive one-stop industrial fermentation CDMO service.
In the field of biotechnology, fermentation refers to any process in which microbes multiply rapidly to produce a variety of valuable compounds. Bacteria (such as E. coli, the most commonly used microorganism in microbial fermentation), algae, fungus, and actinomycetes are among the microorganisms utilized in biotechnological fermentation and enzyme synthesis. BOC Sciences provides seamless one-stop process development services from concept to commercialization, which can help clients promote their project management and meet their project schedules.
Workflow of BOC Sciences' fermentation CDMO service platform
1. Strain selection and optimization
The selected strains need to meet the following conditions:
Support the large-scale production of the required microbial products
Fast growth rate and safe operation
Compatible with media
Low production cost
Conducive to isolation procedures in the fermentation process
Stable and easy to genetic manipulation
After strain selection, strain optimization can be achieved through mutation and selection processes.
2. Media and process development
The culture medium needs to meet the following criteria:
Maximum production capacity of the required product
Allows integrated fermentation process development and manufacturing to run at the highest possible speed
Produces very small amounts of unwanted by-products.
Consistent quality
After the selection of the medium, the fermentation process needs to be integrated and developed to determine the GMP manufacturing route of the microbial drugs from the early stage to the clinical and commercial supply.
3. Fermentation and scale-up
Large-scale fermentation can be achieved through three methods: batch culture fermentation, fed-batch fermentation, and continuous fermentation.
4. Downstream processing
BOC Sciences provides an extensive collection of downstream processing services, including microfiltration, centrifugation, liquid/liquid extraction, ultrafiltration, evaporation, and packaging.
Highlights of BOC Sciences' Fermentation CDMO Platform
Full-service package from intermediate to API, from fermentation to synthesis, and from small molecule drugs to macromolecules.
Flexible production capabilities and qualified personnel, as well as supporting operations such as QA, Analytics, and EHS.
State-of-the-art facilities cover various products like cytotoxic and sterile products.
Investment in environmental protection measures and skills.
Well-established quality system that has passed a series of official inspections and customer audits.
For more detailed information about the fermentation CDMO service of BOC Sciences, please visit the website: https://bio-fermen.bocsci.com.
About BOC Sciences
BOC Sciences seeks to assist researchers in the sectors of food safety, life sciences, and pharmaceuticals with its professional and high-quality microbial metabolite products and services. Antibiotics, bioactive by-products, enzyme inhibitors, mycotoxins, and other compounds fermented and separated from actinomycetes, bacteria, fungi, plants, and other organisms are all included in BOC Sciences' product catalog. Its ambition is to become the world's most competitive and productive metabolite provider.
With well-established regional markets such as North America and Europe presenting grim to moderate growth opportunities, emerging regions with an increased appetite for processed and packaged foods, confectionaries, and biopharmaceutical products can prove to be the most promising targets for companies in the global microbial fermentation technology market, observes Transparency Market Research in a recent report.
Companies can benefit from the rising set of opportunities in emerging economies such as China, Brazil, and India that have billions of potential consumers seeking a diverse range of microbial fermented products to choose from.Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=25952Therefore, focus on expanding businesses to cater to the rising demand for various food, feed, biosimilar products, and alcoholic beverages in these regions can prove to be an excellent growth strategy for players wanting to make it big in the global microbial fermentation technology market in the near future.
Some of the leading companies in the market are Biocon, Lonza, Danone Ltd., Amyris, United Breweries Ltd., Novozymes, TerraVia Holdings, Inc., F. Hoffmann La-Roche Ltd., and BioVectra, DSM.According to the report, the global microbial fermentation technology market was valued at US$1,493.8 bn in 2016 and is projected to expand at a CAGR of 5.7% from 2017 to 2025 to rise to a valuation of US$2,447.5 bn in 2025.Request COVID Analysis on Microbial Fermentation Technology Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=25952Asia Pacific Region to remain a key Consumer of Microbial Fermentation TechnologiesGeographically, the market in Asia Pacific dominated with nearly 40% share in the global market in 2016.
Growth of the regional market can be attributed to the vast rise in geriatric population, a well-established chemical industry in China, cutting-edge research in the field of biotechnology and health care, and changing lifestyles in developing nations.
The thriving nutraceuticals market in India is also likely to fuel the microbial fermentation technology market in Asia Pacific.In terms of product type, the segment of alcoholic beverages accounted for the dominant share in the overall market in 2016 and the trend is likely to remain strong over the forecast period as well, thanks to the expanding urban population and the rising popularity of alcohol among the young population of the globe.Request Customization on Microbial Fermentation Technology Market Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=CR_id=25952Increased Usage of Microbial Fermentation in Biotechnology to Help Market Pick PaceFermentation technology has remained a highly favored biological process across a number of industrial applications for many decades due to low cost, high specificity, simplicity of reaction, and usage in versatile applications.
While microbial fermentation has been used traditionally for preservation of foods only, it has seen a vast rise in application in the past few years owing to promising outcomes and the possibility of development of various bioprocess and products with its help.Modern industry has complemented the basic principle of fermentation technology with advances in genetic engineering by extending applications to produce a vast range products in the biotechnology sector, including biofuels, biochemicals, biopharmaceuticals, biosimilars, and biomolecules.
It is considering the year 2021 as a base year and forecast period for predicting the growth of the market is 2021-2026.
IMR Market Reports is delivering the reports of market research on several categories by an organized method of judging the client, examining market supply, researching, struggle and demand, accompanied by integrating the feedback of the client.
In the competitive analysis section of the report, leading as well as prominent players of the global Metacycline market are broadly studied on the basis of key factors.
The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021.
It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2016-2021.To identify the key drivers and the competitors’ insights, Request a Sample @: https://www.imrmarketreports.com/request/14598Top Key Players studied in Metacycline Market:Merck (USA), Boc Sciences (USA), Manus Aktteva Biopharma (India), Cayman Chemical (USA), Hycultec (Germany)Research MethodologyThe data collected comes from a variety of services, including both primary and secondary sources.
Along with the various weaknesses faced by the company, the strengths are included in the report along with a comprehensive analysis of the various threats and opportunities that can be exploited.Global Metacycline Market Segmented by Product Type:Chronic Bronchitis, Rickettsial Infections, OthersGlobal Metacycline Market Segmented by Application:Clinics, HospitalsFollowing regions are highlighted in this report: North America (United States, Canada and Mexico),Europe (Germany, France, UK, Russia and Italy),Asia-Pacific (China, Japan, Korea, India and Southeast Asia),South America (Brazil, Argentina, etc.
